A NIR-II absorbing conjugated polymer based on tetra-fused isoindigo with ultrahigh photothermal conversion efficiency for cancer therapy
Chemical Communications · 2024
DOI: 10.1039/d4cc02546f ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Communications, 2024. Verfasst von Junjie Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nantong University, Nantong, Jiangsu, 226019, P. R. China. yujiang@ntu.edu.cn. Hauptthemen laut MEDLINE: Polymers, Infrared Rays, Antineoplastic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
A fused polycyclic acceptor–acceptor type conjugated polymer was synthesized. Ultrastrong ε of 62.8 L g −1 cm −1 and high photothermal conversion efficiency of 91.5% at 1064 nm were obtained simultaneously.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Nantong University, Nantong, Jiangsu, 226019, P. R. China. yujiang@ntu.edu.cn.
- School of Materials Science and Engineering, Tianjin University, Tianjin 300072, P. R. China.
ORCID-Profile: Yu Jiang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wu, J., Rao, M., Zhu, Y., Wang, P., Chen, M., Qu, Y., Zheng, X., & Jiang, Y. (2024). A NIR-II absorbing conjugated polymer based on tetra-fused isoindigo with ultrahigh photothermal conversion efficiency for cancer therapy. Chemical Communications. https://doi.org/10.1039/d4cc02546f
Vancouver
Wu J, Rao M, Zhu Y, Wang P, Chen M, Qu Y, et al. A NIR-II absorbing conjugated polymer based on tetra-fused isoindigo with ultrahigh photothermal conversion efficiency for cancer therapy. Chemical Communications. 2024. doi:10.1039/d4cc02546f
BibTeX
@article{Wu2024,
author = {Wu, Junjie and Rao, Mei and Zhu, Yangwei and Wang, Pai and Chen, Min and Qu, Yijie and Zheng, Xiaohua and Jiang, Yu},
title = {A NIR-II absorbing conjugated polymer based on tetra-fused isoindigo with ultrahigh photothermal conversion efficiency for cancer therapy},
journal = {Chemical Communications},
year = {2024},
doi = {10.1039/d4cc02546f}
}
EUVIMED